New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma

Biomarkers

Volumn 14, Issue 5, 2009, Pages 340-346

  Xu, Shu Yong ^a   Liu, Zan ^a   Ma, Wen Jing ^a   Sheyhidin, Ilyar ^a   Zheng, Shu Tao ^a   Lu, Xiao Mei ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Bioinformatics; ESCC; SELDI TOF MS; SVM

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; TUMOR MARKER;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RATING SCALE; SCREENING; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION STUDY; ADULT; AGED; BLOOD; CASE CONTROL STUDY; ESOPHAGUS TUMOR; MIDDLE AGED; PROTEOMICS; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 70149119195     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500902903055     Document Type: Article

References (47)

1. Appella E, Anderson CW. (2007). New prospects for proteomics electron-capture (ECD) and electron-transfer dissociation (ETD) fragmentation techniques and combined fractional diagonal chromatography (COFRADIC). Fed Eur Biochem Soc J 274:6255.
2. Brown MP, Grundy WN, Lin D, Cristianini N, Sugnet CW, Furey TS, Ares M Jr, Haussler D. (2000). Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA 97:262-267
3. Cui JF, Liu YK, Zhou HJ, Kang XN, Huang C, He YF, Tang ZY, Uemura T. (2008). Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis. World J Gastroenterol 14:1257-1262
4. Du XL, Hu H, Lin DC, Xia SH, Shen XM, Zhang Y, Luo ML, Feng YB, Cai Y, Xu X, Han YL, Zhan QM, Wang MR. (2007). Proteomic profiling of proteins dysregulated in Chinese esophageal squamous cell carcinoma. J Mol Med 85:863-875
5. Feng XS, Wang LD, Shan TY, Guo T, Li JL, Fan ZM, Jiao XY, Chang ZH, Gao SG, Han J, and others (2007). Proteomic analysis on esophageal cancer with lymph node metastasis. J Zhengzhou University (Med Sci) 42:397-399
6. Fujita Y, Nakanishi T, Miyamoto Y, Hiramatsu M, Mabuchi H, Miyamoto A, Shimizu A, Takubo T, Tanigawa N. (2008). Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma. Cancer Lett 263:280-290
7. Goncalves A, Bertucci F, Birnbaum D, Borg JP. (2007). Proteic profiling SELDI-TOF and breast cancer: clinical potential applications. Med Sci (Paris) 23:23-26
8. Graham DR, Elliott ST, Van Eyk JE. (2005). Broad-based proteomic strategies: A practical guide to proteomics and functional screening. J Physiol 563:1-9.
9. Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ. (2008). Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-offlight mass spectrometry. Am J Clin Oncol 31:133-139
10. He M, Qin J, Zhai R, Wei X, Wang Q, Rong M, Jiang Z, Huang Y, Zhang Z. (2008). Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach. Proteome Sci 6:10-20.
11. Hellström M, Lexander H, Franzén B, Egevad L. (2007). Proteomics in prostate cancer research. Anal Quant Cytol Histol 29:32-40.
12. Hu YC, Lam KY, Law S, Wong J, Srivastava G. (2001). Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by Cdna expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 7:2213-2221 (Pubitemid 32751617)
13. Hundt S, Haug U, Brenner H. (2007). Blood markers for early detection of colorectal cancer: A systematic review. Cancer Epidemiol Biomarkers Prev 16:1935-1953
14. Jain KK. (2002). Role of proteomics in diagnosis of cancer. Technol Cancer Res Treat 1:281-286
15. Kawaguchi H, Ohno S, Miyazaki M, Hashimoto K, Eqashira A, Saeki H, Watanabe M, Suqimachi K. (2000). CYFRA21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences. Cancer 89:1413-1417
16. Lange V, Picotti P, Domon B, Aebersold R. (2008). Selected reaction monitoring for quantitative proteomics: A tutorial. Mol Syst Biol 4:222.
17. Langer R, Ott K, Specht K, Becker K, Lordick F, Burian M, Herrmann K, Schrattenholz A, Cahill MA, Schwaiger M, Hofler H, Wester HJ. (2008). Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response. Clin Cancer Res 14:8279-8287
18. Leong S, Christopherson RI, Baxter RC. (2007). Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry. Cell Physiol Biochem 20:579-590
19. Lightdale CJ. (1999). Esophageal cancer. American College of Gastroenterology. Am J Gastroenterol 94:20-29
20. Liu CZ, Zhu PY, Shi MX, Liu JB, Wang WJ, Liao P, Xiang PP, Zhang YX. (2007). Screening of serum proteome biomarker of esophageal squamous cell carcinoma by WCX2 proteinchip. China Oncol 17:701-705
21. Liu J, Zheng S, Yu JK, Zhang JM, Chen Z. (2005). Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor. J Zhejiang University Sci 6:4-10.
22. Lu JB, Yang WX, Zu SK, Chang QL, Sun XB, Lu WQ, Quan PL, Qin YM. (1988). Cancer mortality and mortality trends in Henan, China, 1974-1985. Cancer Detect Prev 13:167-173
23. Mao YS, Zhang DC, Zhao XH, Wang LJ, Qi J, Li XX. (2003). Significance of CEA, SCC, and Cyfra21-1 serum test in esophageal cancer. Chinese J Oncol 25:457-460
24. Merchant M, Weinberger SR. (2000). Recent advancements in surface- enhanced laser desorption/ionization-time of flightmass spectrometry. Electrophoresis 21:1164-1177
25. Muir CS, McKinney PA. (1992). Cancer of the esophagus: A global overview. Eur J Cancer Prev 1:259-264
26. Patel PS, Telang SD, Rawal RM, Shah MH. (2005). A review of proteomics in cancer research. Asian Pacific J Cancer Prev 6:113-117
27. Pisani P, Parkin DM, Ferlay J. (1993). Estimates of the worldwide mortality from eighteen major cancers in 1985: Implications for prevention and projections of future burden. Int J Cancer 55:891-903.
28. Qi YJ, He QY, Ma YF, Du YW, Liu GC, Li YJ, Tsao GS, Ngai SM, Chiu JF. (2008). Proteomic identification of malignant transformationrelated proteins in esophageal squamous cell carcinoma. J Cell Biochem 104:1625-1635
29. Rai AJ, Chan DW. (2004). Cancer proteomics: serum diagnostics for tumor marker discovery. Ann N Y Acad Sci 1022:286-294
30. Skytt A, Thysell E, Stattin P, Stenman UH, Antti H, Wikström P. (2007). SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer. Int J Cancer 121:615-620
31. Srinivas PR, Srivastava S, Hanash S, Wright GL. (2001). Proteomics in early detection of cancer. Clin Chem 47:1901-1911
32. Toshikatsu, Fumio I, Yokosuka O, Saisho H, Suzuki T, Koide Y, Isono K. (1998). Expression of p53 and p21/WAFI proteins in gastric and esophageal cancer comparison with mutation of the p53 gene. Digest Dis Sci 43:279-283
33. Uemura N, Nakanishi Y, Kato H, Saito S, Nagino M, Hirohashi S, Kondo T. (2008). Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer 124:2106-2115
34. Valkovskaya N, Kayed H, Felix K, Hartmann D, Giese NA, Osinsky SP, Friess H, Kleeff J. (2007). ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer. J Cell Mol Med 11:1162-1174
35. Vapnik V. (1982). Estimation of Dependences Based on Empirical Data. New York: Springer-Verlag.
36. Wang LD, Wang DC, Zheng S, Fan ZM, Li JL, Feng CW, Zhang YR, Liu B, Gao SS, He X, Feng XS. (2006). Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China. Chinese J Cancer 25:549-555
37. Wang LD, Zhou Q, Yang CS. (1997). Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high incidence area. J Cell Biochem Suppl 28-29:159-165
38. Wang Y, Deng BP, Ma LH, Xu Y, Zhang ZS, Liu F, Mao YS, Zhang JS, Zhang DC, Zhao XH. (2004). A serum pattern for the diagnosis of esophageal squamous cell carcinoma. Chinese J Lab Med 27:634-637
39. Ward DG, Nyangoma S, Joy H, Hamilton E, Wei W, Tselepis C, Steven N, Wakelam MJ, Johnson PJ, Ismail T, Martin A. (2008). Proteomic profiling of urine for the detection of colon cancer. Proteome Sci 6:19.
40. Weinberger SR, Boschetti E, Santambien PJ. (2002). Surface-enhanced laser desorption-ionization retentate chromatography mass spectrometry (SELDI-RC-MS): A new method for rapid development of process chromatography conditions. J Chromatogr B Anal Technol Biomed Life Sci 782:307-316
41. Winters-Hilt S, Yelundur A, McChesney C, Landry M. (2006). Support vector machine implementations for classification & clustering. BMC Bioinform 7 (Suppl. 2):S4.
42. Wu SP, Lin YW, Lai HC, Chu TY, Kuo YL, Liu HS. (2006). SELDI-TOF MS profiling of plasma proteins in ovarian cancer. Taiwan J Obstet Gynecol 45:26-32.
43. Xia T, Zheng ZG, Gao Y, Mou HZ, Xu SH, Zhang P, Zhu JQ. (2008). Application of SELDI-TOF serum proteome profiling in cervical squamous cell carcinoma. Ai Zheng 27:279-282
44. Yasui Y, Pepe M, Thompson ML, Adam BL, Wright GL Jr, Qu Y, Potter JD, Winget M, Thornquist M, Feng Z. (2003). A data-analytic strategy for protein biomarker discovery: Profiling of high-dimensional proteomic data for cancer detection. Biostatistics 4:449-463
45. Zhang HL, Gao CF, Wang XL, Li DH, Hu WH. (2007). Application of SELDI-TOF-MS spectrometry in serological diagnosis for esophageal squamous cell carcinoma. Chinese J Clin Lab (Science) 25:280-282
46. Zhang XG, Lu X, Shi Q, Xu XQ, Leung HC, Harris LN, Iqlehart JD, Miron A, Liu JS, Wong WH. (2006). Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data. BMC Bioinform 7:197-210.
47. Zhang YM. (1988). Distribution of esophageal cancer in Xinjiang. Acta Acad Med Xinjiang 11:139-145